Advanced Search
Current and Breaking News for Professionals, Consumers and Media




opiods Author: Staff Editor Last Updated: Nov 19, 2018 - 8:51:13 AM



Concomitant Use of Sleeping Pills and Strong Painkillers is Common Among People with Alzheimer’s Disease

By Staff Editor
Nov 19, 2018 - 8:47:35 AM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page

(HealthNewsDigest.com) - One in five people with Alzheimer’s disease (AD) who use a benzodiazepine are also concomitant users of an opioid, according to a new study from the University of Eastern Finland. Concomitant use was more common in comparison persons, but those with AD used strong opioids more frequently. About half of all concomitant users were prolonged users whose use of these drugs had continued for more than three consecutive months.

Prolonged concomitant use was associated with lung diseases, osteoporosis and previous hip fracture. In addition, a history of substance abuse and previous long-term use of benzodiazepines were related to prolonged concomitant use. In these high-risk patient groups, concomitant use of opioids and benzodiazepines or related drugs may increase the risk of pneumonia, fractures and drug misuse.

The most commonly used drug combination among persons with AD was a benzodiazepine and a weak opioid, while those without AD most commonly used a benzodiazepine related Z-drug and a weak opioid. Those with AD were more commonly prescribed strong opioids than those without AD. The trend may be partly explained by the use of opioid patches that are more commonly used in individuals with AD. In Finland, only buprenorphine and fentanyl are available as patches.

“Concomitant use of drugs that act on the central nervous system in an older population is concerning, as the use of these drugs has been associated with serious risks, especially in frail individuals with AD. Unnecessary co-use of these drugs should be avoided, as the benefits rarely outweigh the risks,” says University Lecturer Niina Karttunen from the University of Eastern Finland.

The study was part of the nationwide register-based MEDALZ study that includes all persons with clinically verified diagnosis of Alzheimer’s disease in Finland during 2005–2011. The study included 70,718 persons diagnosed with Alzheimer’s disease. Data on drug use was extracted from the Finnish Prescription Register. The study was conducted at the University of Eastern Finland and published in International Journal of Geriatric Psychiatry.

For further information, please contact:

Niina Karttunen, PhD, University of Eastern Finland, School of Pharmacy, Kuopio, Finland, niina.karttunen(at)uef.fi

Research article:

Karttunen N, Taipale H, Hamina A, Tanskanen A, Tiihonen J, Tolppanen AM, Hartikainen S. Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer’s disease – A nationwide register-based study in Finland, published online October 29, 2018. DOI: 10.1002/gps.5018



Top of Page

HealthNewsDigest.com

opiods
Latest Headlines


+ Opioid Addiction Crisis in United States Linked to Poor Working Conditions
+ Importance of Monitoring for Post-treatment Opioid Use in Young Sarcoma Patients
+ New App Helps People Struggling With Opioids
+ Mailed Kits Doubles Rate of Leftover Opioids Disposal
+ New Pain Management Approach Reduced Opioid Use After C-Sections
+ Disasters Could Disrupt Care for Opioid Use Disorder in Most Communities
+ Experts Share Their Work Combating Nation’s Opioid Crisis at 2022 Rx Summit
+ INTEGRA Gives Former Opioid User Purpose on His Road to Recovery
+ Programs to Reduce Opioid Use After Urologic Surgery Work
+ Medication Treatment for Opioid Use Disorder



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions